Novum Pharmaceutical Research Services - Ownership and Business Overview

Life ScienceCompany

Novum Pharmaceutical Research Services Ownership

Who owns Novum Pharmaceutical Research Services?

Novum Pharmaceutical Research Services is owned by Lambda Therapeutic Research. It was acquired on January 29, 2019.

Novum Pharmaceutical Research Services Business Overview

Where is Novum Pharmaceutical Research Services headquartered?

Novum Pharmaceutical Research Services is headquartered in Pittsburgh, Pennsylvania.

What sector is Novum Pharmaceutical Research Services in?

Novum Pharmaceutical Research Services is a life science company.

Life Science M&A Summary in 2019

Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2019. The largest life science acquisition in 2019 was Celgene - which was acquired by Bristol-Myers Squibb for $74.0B.

Join Mergr to view all 249 acquisitions of life science companies in 2019, including 44 acquisitions by private equity firms, and 205 by strategics.

Novum Pharmaceutical Research Services

225 W. Station Square Drive, Suite 200,
Pittsburgh, Pennsylvania 15219
United States,
www.novumprs.com

Novum Pharmaceutical Research Services is full-service offerings provide a hassle-free, turnkey solution for drug development programs to advance the availability of quality medicine. Novum Pharmaceutical Research Services is based in Pittsburgh, Pennsylvania.


 Subscribe to unlock this and 207,673
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.